The anniversary celebration for the line-smoothing, migraine-relieving medication is expected to last a year.
Endo gets a new president, Allergan settles a Botox case
An April 25 JAMA article said Botox does nothing for episodic migraine patients. Allergan brushed off the critique.
US District Court Judge Andrew Guilford slammed the breaks on Merz's foray into a market dominated by Botox, siding with Allergan in a case about stealing intellectual property and poaching sales reps.
Allergan removed some doctor-payment records from its website that the drugmaker had posted from 2010-2011 as a result of a Botox legal settlement.
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.